Document Classification

Section Type: RESULTS

Text: Patients assigned to fondaparinux compared with enoxaparin had a significantly lower mean anti-Xa level [0. 52 IU mL (-1) (SD 0. 22 IU mL (-1)) vs. 1. 2 IU mL (-1) (SD 0. 45 IU mL (-1)), P < 0. 0001] and Xa clot time [64. 9 s (SD 17. 7 s) vs. 111. 8 s (SD 29. 6 s), P < 0. 0001], and significantly higher ETP area under the curve (AUC) [386. 7 mA (SD 51. 5 mA) vs. 206. 4 mA (SD 90. 6 mA), P < 0. 001] at 6 h, and these differences remained evident at 24 and 72 h.